Retina I: Retina is a Fine Wine: the Dryer the Better
My Session Status
At the end of this session, participants will be able to:
- To understand the incredible advancements that continue to be made in the management of age related macular degeneration.
- Appreciate how to select the best therapeutic option to minimize vision loss in macular degeneration.
- Realize the risk factors that contribute to the advancement of macular degeneration.
CanMEDS: Medical Expert, Scholar
Sub Sessions
Author’s Name(s): Raman Tuli, Jeffrey Heier, Nathan Steinle, David Boyer, Ashkan Abbey, David Eichenbaum, Frank Holz, Mathew MacCumber, Caroline Baumal, Charles WykoffAuthor’s Disclosure Block: Raman Tuli: Bayer, Roche, Apotex, Membership on an advisory panel, standing committee or board of directors; Jeffrey Heier: consultant: 4DMT, AbbVie, Adverum, Affamed, AGTC, Akouos, Alimera Sciences, Allgenesis, Alzheon, American Genomics, Annexon, Apellis, Ascl...
Author’s Name(s): Wai-Ching Lam, Timothy Lai, Xiaodong Sun, Shih-Jen Chen, Xin Zhang, Andrea Schulze, Tobias Machewitz, Min Zhao, Sergio LealAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Apellis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Novartis, Membership on an advisory panel, standing committee or board of directors, Amgen, Membership on an advi...
Author’s Name(s): Rajinder Nirwan, Robert L. Avery, Sara J. Haug, David Tabano, Gloria Chi, Manuel Amador, Aachal Kotecha, Philippe Margaron, Ming Yang Author’s Disclosure Block: Rajinder Nirwan: Roche, Employment/honoraria/consulting fees; Robert L. Avery: Consultant: Adverum, Alcon, Alimera, Allergan, Amgen, Apellis, AsclepiX, Bausch + Lomb, Cardinal, Clearside Biomedical, Coherus, EyePoint, Genentech, Inc., Helio Vision, InFocus Capital Partner...
Author’s Name(s): David Wong, Praveen Patel, Paolo Lanzetta, Jean-François Korobelnik, Sobha Sivaprasad, Sergio Leal, Tobias Machewitz, Xin ZhangAuthor’s Disclosure Block: David Wong: Alcon, Employment/honoraria/consulting fees, Abbviw, Employment/honoraria/consulting fees, Apellis, Employment/honoraria/consulting fees, Astellas, Employment/honoraria/consulting fees, Bayer, Grant/research support, Roche, Employment/honoraria/consulting fees, Zeiss, Emp...
Author’s Name(s): Mélanie Hébert, Valérie Gagné, Jean-Philippe Rozon, Serge Bourgault, Mathieu Caissie, Laurence Letartre, Éric Tourville, Ali DiraniAuthor’s Disclosure Block: Mélanie Hébert: Bayer, Grant/research support, Vision Health Research Network, Grant/research support, Fighting Blindness Canada, Grant/research support; Valérie Gagné: none; Jean-Philippe Rozon: none; Serge Bourgault: none; Mathieu Caissie: none; Laurence Letartre: none; Éric To...
Author’s Name(s): Reut Shor, Andrew Mihalache, Atefeh Noori, Renana Shor, Radha Kohly, Marko Popovic, Rajeev MuniAuthor’s Disclosure Block: Reut Shor, none; Andrew Mihalache, none; Atefeh Noori, none; Renana Shor, none; Radha Kohly, none; Marko Popovic, none; Rajeev Muni, noneAbstract BodyPurpose: To determine whether glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated with increased risk of developing neova...
Author’s Name(s): Andrew Mihalache, Ryan Huang, Marko Popovic, Sue Demian, Rajeev MuniAuthor’s Disclosure Block: Andrew Mihalache: none; Ryan Huang: none; Marko Popovic: Financial support (to institution) – PSI Foundation, Fighting Blindness Canada.; Sue Demian: none; Rajeev Muni: Consultant – Alcon, Apellis, AbbVie, Bayer, Bausch Health, Roche; Financial Support (to institution) – Alcon, AbbVie, Bayer, Novartis, Roche.Abstract Body